Drugs / DCV3
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02767193 | May 2016 → May 2019 | HIV infectious disease | Judit Pich Martínez | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DCV3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02767193 ↗ |
| Modality | Vaccine | “therapeutic vaccine produced with monocyte-derived dendritic cells (MD-DC) loaded with a high dose of heat-inactivated autologous (HIA) HIV-1” PMID 34858423 ↗ Nov 2021 |